Mandolin
Mandolin is a San Francisco-based AI agent platform, founded in 2024, that automates end-to-end back-office workflows (intake, benefits verification, prior authorization, claims) for U.S. infusion centers, specialty pharmacies, and health systems administering specialty drugs.
- Company typePrivate
- Founded2024
- HeadquartersSan Francisco, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Mandolin does
Mandolin (legally Coral Automation, Inc.) is a San Francisco-based AI automation company founded in 2024 that builds an agentic platform for the back-office workflows governing specialty drug access. The company targets infusion centers, specialty pharmacies, and health systems that administer high-cost infused and injectable therapies for conditions including cancer, Alzheimer's, and immune disorders. Its core proposition is replacing fragmented manual workflows across intake, benefits verification, prior authorization, patient out-of-pocket estimation, and claims status tracking with AI agents that navigate EHR systems, payer portals, faxes, and phone calls autonomously.
The platform is organized as an "Agentic Operating System" with multiple integrated modules, each addressing a distinct step in the specialty drug revenue cycle: Intake and Onboarding, Benefits Verification, Patient Out-of-Pocket Estimation, Medical Policy Review and Prior Authorization, Claims Statusing and Appeal Automation, and Compliance and Audit. The technology stack combines multimodal AI (vision, language, and structured data processing) with a workflow engine that requires no APIs or third-party integrations from customers. Documented outcomes include a 24x improvement in document processing speed (from 20 minutes per document with 3-day turnaround to 3 minutes with under-2-hour turnaround), elimination of multi-day prescription backlogs, and scaling a national AIC customer to 4,500+ patients/month without adding headcount. The company is HIPAA-compliant, operating as a Business Associate under BAA agreements with covered entities, and trains its AI on de-identified data.
Mandolin operates a B2B enterprise SaaS model with quote-based pricing to healthcare providers. As of mid-2025 the platform is deployed across more than 700 clinic locations serving approximately 250,000 new patients annually through flagship customers including Vivo Infusion, Amber Pharmacy, FlexCare Infusion, and TwelveStone Health Partners. The company has raised $40M in Series A funding led by Greylock Partners (June 2025) following an earlier seed round co-led by SignalFire and Maverick, and employs 101-250 staff with active hiring across infrastructure, ML, security, and product functions. Geographic operations are currently United States-only.
Mandolin firmographics
Firmographics- Name
- Mandolin
- Legal name
- Coral Automation, Inc.
- Website
- https://mandolin.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Mandolin is a San Francisco-based AI agent platform, founded in 2024, that automates end-to-end back-office workflows (intake, benefits verification, prior authorization, claims) for U.S. infusion centers, specialty pharmacies, and health systems administering specialty drugs.
- Ownership category
- akta.pro rank
Mandolin industry classification
Industry- Product category
- Healthcare Workflow Automation Software
- NAICS
- Software Publishers (5132), Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
- akta.pro secondary industries
- Patient Intake, Digital Registration & eForms (HLACAEAF), RPM Reimbursement, Billing & Program Operations Platforms (HLACAFAN), Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK)
Keywords
Where Mandolin is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Mandolin business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Healthcare SaaS Platform Subscription: SaaS platform providing AI automation services for specialty drug access workflows including intake, benefits verification, prior authorizations, and revenue cycle management
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Mandolin product offering
Product offeringCore offering
Mandolin provides an AI agent platform that automates the end-to-end administrative lifecycle for specialty drug access, including patient intake and onboarding, benefits verification, prior authorization, patient out-of-pocket estimation, claims statusing, appeals, and compliance/audit. The platform is sold as a healthcare SaaS subscription to infusion centers, specialty pharmacies, and health systems, and is designed to operate without APIs or customer-built integrations, replacing fragmented back-office workflows with AI agents that navigate payer portals, read faxes, and make phone calls.
Product overview
Mandolin is a unified AI automation platform for specialty drug access, consisting of an Agentic Operating System with multiple integrated modules covering the end-to-end administrative workflow: Intake & Onboarding, Benefits Verification, Patient Out-Of-Pocket Estimation, Medical Policy Review & Prior Authorization, Claims Statusing and Appeal Automation, and Compliance & Audit. The platform uses AI agents to automate administrative processes for infused and injectable drug delivery, reducing treatment time from weeks to days.
Differentiator
Problem solved
Functional benefit
Products and services
- Mandolin AI Agent Platform Healthcare SaaS platform that uses AI agents to automate the end-to-end administrative lifecycle for specialty drug access, including patient intake, benefits verification, prior authorization, patient out-of-pocket estimation, claims statusing, appeals, and compliance/audit. It is sold to infusion centers, specialty pharmacies, and health systems and operates without requiring APIs or customer-built integrations.
Quantifiable outcome
- 24x improvement in document processing speed - from 20 minutes per document with 3-day turnaround to 3 minutes per document with under 2 hours end-to-end
- +3 more outcomes
Companies that use Mandolin
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Mandolin technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature6 records
Mandolin partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights5 records
Mandolin competitors and assessment
Company assessmentEmerging players
- Cedar: Patient financial experience and billing platform for specialty providers; relevant adjacent peer addressing the same specialty drug patient financial workflow.
- Avizia (now part of Cohere Health): Prior authorization automation acquired by Cohere; historically competed in specialty drug prior auth—illustrative of the category Mandolin is operating in.
Direct peers
- Alpha II: Provides claims editing, coding, and revenue cycle analytics with a focus on specialty pharmacy and infusion billing workflows; adjacent automation for the same buyer.
- Infinx Healthcare: Provides AI-driven prior authorization, eligibility verification, and revenue cycle management specifically for specialty practices and infusion centers—the most direct head-to-head competitor to Mandolin.
- AKASA: AI platform automating revenue cycle operations for health systems, including prior authorization, claims, and appeals—directly competitive with Mandolin's RCM modules.
- Cohere Health: AI-powered prior authorization and specialty care management platform working with health plans and providers; overlaps directly with Mandolin's prior auth and benefits verification modules.
- Anterior (formerly Knownwell): AI clinical reasoning platform that automates prior authorization and medical necessity decisions for specialty care; comparable end-to-end agent architecture and use case.
- Humata Health: Specializes in AI-powered prior authorization for specialty drugs and complex therapies, addressing the same payer-provider workflow as Mandolin's Medical Policy Review module.
Broad incumbents
- Waystar: Large, established healthcare payments and RCM platform with eligibility, prior auth, and claims modules; broader portfolio but overlapping with Mandolin's revenue cycle modules.
- Olive AI: Healthcare AI automation platform targeting revenue cycle and administrative workflows at health systems; broader scope than Mandolin but overlapping automation thesis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Mandolin social profiles
Digital presenceMandolin compliance and trust
Trust signalCompliance1 record
Mandolin financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mandolin leadership team
Management profileNumber of profiles
Profiles2 records
Mandolin funding detail
Funding detailFunding overview
Funding rounds1 record
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mandolin M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mandolin
What does Mandolin do?
Mandolin provides an AI agent platform that automates the end-to-end administrative lifecycle for specialty drug access, including patient intake and onboarding, benefits verification, prior authorization, patient out-of-pocket estimation, claims statusing, appeals, and compliance/audit. The platform is sold as a healthcare SaaS subscription to infusion centers, specialty pharmacies, and health systems, and is designed to operate without APIs or customer-built integrations, replacing fragmented back-office workflows with AI agents that navigate payer portals, read faxes, and make phone calls.
Is Mandolin a public or private company?
Mandolin is a private company. It is classified as venture growth investor backed and is currently operating.
When was Mandolin founded?
Mandolin was founded in 2024. It employs 101 to 250 people.
Where is Mandolin based?
Mandolin is headquartered in San Francisco, United States, in the North America region.
How does Mandolin make money?
One revenue line is on record: healthcare SaaS Platform Subscription.
Who are Mandolin's main competitors?
Emerging players on record are Cedar and Avizia (now part of Cohere Health). Direct peers are Alpha II, Infinx Healthcare, AKASA, Cohere Health, Anterior (formerly Knownwell) and Humata Health. Broad incumbents are Waystar and Olive AI.
Does Mandolin have an API?
No public API is recorded for Mandolin.
What industry is Mandolin in?
Mandolin's product category is Healthcare Workflow Automation Software. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of HLACAEAF, Patient Intake, Digital Registration & eForms. Its NAICS code is 5132 and its SIC code is 7372.